Cholesterol depletion form human glioma cells using methyl-β-cyclodextrin (MβCD), an agent frequently used to disrupt lipid rafts, results in increased CD44 shedding, which was mediated by a transmembrane protease a disintegrin and metalloproteinase 10 (ADAM10). Here, CD44 is linked to central nervous system cancer.